Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke.
Launched by UNIVERSITY OF IOANNINA · Apr 29, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how nutrition, specifically the use of protein supplements, can help patients who have had a stroke and are experiencing low protein levels in their blood, a condition known as hypoalbuminemia. The goal is to see if providing either a single or double dose of protein supplements can improve recovery in these patients, especially in terms of muscle strength, bone health, and overall physical functioning. Participants will be divided into three groups: one will not receive any protein supplements, while the other two groups will receive either a single or double dose for at least six weeks. Throughout the study, researchers will closely monitor various health markers and physical abilities to understand the impact of nutrition on recovery.
To participate in this trial, individuals must be between the ages of 18 and 85, have had a stroke in the past 4 to 6 weeks, and have low levels of protein in their blood. They should also be in need of nutritional support for recovery. However, those with severe infections, serious heart or lung issues, certain other health conditions, or severe mental health challenges that prevent them from understanding or consenting to the study will not be eligible. This research is important because it aims to improve how we support stroke recovery through better nutritional strategies, potentially leading to new guidelines for treating patients with low protein levels.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age range: Adults aged 18 to 85 years
- • Diagnosis: Patients diagnosed with a stroke (cerebrovascular accident) within the last 4 to 6 weeks
- • Serum albumin levels: Patients with low serum albumin levels (\< 3.5 g / dL)
- • Nutritional intervention requirement: Patients who require nutritional intervention to support rehabilitation and nutrition
- • Informed consent: Patients who have completed the consent form for participation in the study and acceptance of the intervention
- Exclusion Criteria:
- • Severe infections or serious cardiopulmonary conditions: Patients with severe infections or serious cardiopulmonary conditions requiring immediate medical intervention, which may affect nutrition and rehabilitation
- • Comorbidities: Patients with comorbid conditions such as renal or liver disease
- • History of stroke or neurological conditions: Patients with a history of stroke or other neurological conditions who do not meet the criteria for rehabilitation
- • Severe mental or psychological conditions: Patients with severe mental or psychological conditions who are unable to understand or consent to participation in the study
About University Of Ioannina
The University of Ioannina, located in Greece, is a leading academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving healthcare outcomes. With a focus on collaborative research, the University of Ioannina engages in multidisciplinary partnerships and adheres to rigorous ethical standards, ensuring the integrity and reliability of its clinical trials. Through its dedication to scientific excellence, the university aims to contribute significantly to the body of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ioannina, , Greece
Patients applied
Trial Officials
Avraam Ploumis
Principal Investigator
University Hospital, Ioannina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported